Clinical Study Results
Research Sponsor: MedImmune LLC
Treatments Studied: MEDI5083 and durvalumab
Study Purpose: This study was done to learn about the
safety of MEDI5083 and durvalumab in
participants with advanced solid tumors
Protocol Number: D6840C00001
Thank you
Thank you for taking part in the clinical study for the study treatments MEDI5083
and durvalumab.
MedImmune LLC sponsored this study and believes it is important to share the
results. An independent non-profit organization called CISCRP helped prepare this
summary of the study results for you.
If you participated in the study and have questions about the results, please speak
with the study doctor or staff at your study site.
1